Cefoperazone and Beta-Lactamase Inhibitor shortage in Japan

Is there a Cefoperazone and Beta-Lactamase Inhibitor shortage in Japan?

Yes. As of 2 Nov 2026, 2 Cefoperazone and Beta-Lactamase Inhibitor products are reported short in Japan, the first since 14 Feb 2025. No return date has been given. Main reason: increased demand.

Not reported short in any other country we track. All countries.

Affected products in Japan

Country	Product	Company	Since	Expected back	Reason
JP	ワイスタール配合静注用1g limited	Nipro	14 Feb 2025	not given	Increased demand
JP	セフォセフ静注用1g limited	Sawai	10 Apr 2026	not given	Active ingredient shortage Raw material (active ingredient) supply problem

Source

MHLW (Ministry of Health, Labour and Welfare), supply status of prescription medicines. Official list. Prescription products under limited shipment or supply suspension (delistings excluded); one row per product.